Amarin Corp PLC (AMRN): Gross Profit
$120.87M
Year ended 2025-12-31
$78.14M
Trailing 12 months to 2026-06-30
-20.7%
3-year compound annual growth
-24.2%
5-year compound annual growth
+8.4%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $120.87M | +48.5% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $81.38M | -50.8% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $165.54M | -31.7% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $242.48M | -47.5% | 2025-03-12, From 2022-01-01 |
| 2021-12-31 | $461.86M | -4.3% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $482.62M | +44.6% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $333.74M | +91.1% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $174.67M | +28.3% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $136.15M | +42.2% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $95.72M | +77.7% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $53.88M | +59.8% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $33.72M | +133.5% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $14.44M | n/a | 2016-02-25, From 2013-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Amarin Corp PLC (AMRN) | 2025-12-31 | $120.87M | +48.5% |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $170.21M | +2.5% |
| Akebia Therapeutics, Inc. (AKBA) | 2025-12-31 | $196.73M | +102.8% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $170.26M | +45.8% |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | $33.99M | -68.6% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $141.61M | -22.9% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $142.61M | +8.0% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $83.05M | +19.2% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $152.51M | +222.6% |
Compare AMRN, PBYI, AKBA, RYTM side by side · Screen every company in Pharmaceutical Preparations ↗